America Ferrera, the award-winning actress who is best known for her portrayal of Betty Suarez in the hit comedy Ugly Betty, will speak at Bunker Hill Community College on Thursday, February 16, 2012.

Ferrera’s role in this TV show landed her some of the highest accolades in the entertainment industry: an Emmy, a Golden Globe and a Screen Actors Guild Award, as well as ALMA and Imagen awards.

Her starring role in Real Women Have Curves resulted in numerous other honors, including a Sundance Jury Award for best actress. Ferrera both starred in and was executive producer of The Dry Land, the story of a soldier returning home to Texas after the war in Iraq, which won the award for Best International Film at the 2010 Edinburgh Film Festival.

Ferrera is also widely known for her humanitarian work. She has devoted her time to a range of humanitarian organizations, including Save the Children, which promotes education for children in need. For her commitment to educating youth in Mali, she received the 2011 Global Action Award for Childhood Development and Education.

Ferrera will speak about how education has helped her achieve success, and the importance of “giving back” to the global community to help those who are less fortunate.

BHCC’s “Compelling Conversations” speaker series has brought renowned authors, artists and activists to its campus. Past speakers have included New York Times writer Gail Collins, civil rights activist Rubin “Hurricane” Carter and award-winning filmmaker and author Michael Moore.

Bunker Hill Community College is the largest community college in Massachusetts.

comments powered by Disqus

Latest news

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation Nov 5, 2024

Last week, in a special evening honoring John Mayer and Jeff Ross, Cool Comedy • Hot Cuisine raised more than $1.3 million for the Scleroderma Research Foundation (SRF)—the country’s first and leading nonprofit investor in medical research into scleroderma. More
More news